To test this conjecture, we used the NF-κB inhibitor QNZ-EVP4593 in CD146-overexpressing HCC cells, which reported the protein levels of JAG2, NOTCH1 and HES1 were down-regulated. The gene discussed is JAG2; the disease is hepatocellular carcinoma.